INOVIQ (IIQ) Stock Overview

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample. Its cancer diagnostic pipeline includes blood tests in development for ovarian, breast, and other cancers. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was incorporated in 1983 and is headquartered in Notting Hill, Australia.

IIQ Stock Information

Symbol

IIQ

Address

23 Normanby RoadNotting Hill, VIC 3168Australia

Founded

Trading hours

10:00 AM - 4:00 PM AEST

Website

https://www.inoviq.com

Country

🇦🇺 Australia

Phone Number

61 3 9548 7586

INOVIQ (IIQ) Price Chart

INOVIQ Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.37555826228177025	N/A
Market Cap	$34.56M	N/A
Shares Outstanding	92.02M	1.28%
Employees	0	N/A
Shareholder Equity	19.62M	-30.67%

Valuation	2023	Change
P/S Ratio	128.26	N/A
P/B Ratio	1.76	N/A

Growth	2023	Change
Return on Equity	-0.3094	N/A

Earnings	2023	Change
Revenue	$269.45K	N/A
Earnings	-$6.07M	N/A
Gross Margin	0.8883	N/A
Operating Margin	-26.31	N/A
Net income margin	-22.52	N/A

Financial Strength	2023	Change
Total Assets	$14.55M	N/A
Total Debt	$494.46K	N/A
Cash on Hand	$5.29M	N/A
Debt to Equity	0.0653	9.83%
Cash to Debt	$10.69	-30.64%
Current Ratio	$6.20	-36.31%